Utility of FDG PET and Cardiac MRI in Diagnosis and Monitoring of Immunosuppressive Treatment in Cardiac Sarcoidosis – Radiology: Cardiothoracic Imaging
Posted: June 23, 2021
Authors: Richard A. Coulden, MBBS • Emer P. Sonnex, MPhil • Jonathan T. Abele, MD • Andrew M. Crean, MBBS, MPhil
Purpose: To compare the contributions of cardiac MRI and PET in the diagnosis and management of cardiac sarcoidosis (CS), with particular reference to quantitative measures.
Latest News
info@acmdtt.com
780.487.6130 or 587.404.2384
1.800.282.2165
800-4445 Calgary Trail
Edmonton AB Canada T6H 5R7
Monday – Friday
8:30 AM – 12:00 PM
1:00 PM – 4:30 PM
By appointment only
to ensure accommodation.
© Copyright 2024 | Alberta College of Medical Diagnostic and Therapeutic Technologists. All Rights Reserved.